Focus: Zura Bio is a public-stage monoclonal antibody biotechnology company focused on oncology and autoimmune diseases, headquartered in La Jolla, CA. The company is in early clinical development with a lean portfolio centered on tibulizumab.
Profile data last refreshed Yesterday · AI intelligence enriched 3w ago
No open roles listed right now. Follow Zura Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Zura Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Zura Bio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Zura Bio navigates growth path amid biotech volatility - Ad Hoc News
Zura Bio navigates growth path amid biotech volatility Ad Hoc News
Zura Bio (NASDAQ: ZURA) furnishes updated corporate presentation for investors - Stock Titan
Zura Bio (NASDAQ: ZURA) furnishes updated corporate presentation for investors Stock Titan
We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely - simplywall.st
We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely simplywall.st
8-K Filing: Jade Biosciences, Inc. (JBIO) (CIK 0001798749) — 8-K
8-K
Zura Bio Ltd stock (KYG989201089): pipeline update keeps autoimmune story in focus - AD HOC NEWS
Zura Bio Ltd stock (KYG989201089): pipeline update keeps autoimmune story in focus AD HOC NEWS
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer - Business Wire
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer Business Wire
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo